News

Our Healthcare News

EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for First-Line Treatment

HEMEL HEMPSTEAD, England – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the…  

Jun 23 2017

Endologix Provides an Update on the Nellix Endovascular Aneurysm Sealing System US Regulatory Status

IRVINE, California – Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that the Company met with the…  

May 17 2017

European Commission Approves the Only Immunotherapy for High-Risk Neuroblastoma

HEMEL HEMPSTEAD, England – EUSA Pharma today announced that the European Commission (EC) has approved the antibody ch14.18/CHO, dinutuximab beta, for the treatment of high-risk…  

May 09 2017

EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for Dinutuximab Beta

HEMEL HEMPSTEAD, England and VIENNA, Austria – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, and…  

Mar 27 2017

Xenex Secures $38 Million in Funding Led by Essex Woodlands & Piper Jaffray Merchant Banking

SAN ANTONIO, Texas—Xenex Disinfection Services, the manufacturer of LightStrike Germ-Zapping Robots™, today announced the investment of $38 million in a funding round led by Essex…  

Feb 24 2017

Endologix Completes Patient Enrollment in the Ovation LUCY Study

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the…  

Feb 14 2017

Prolacta Bioscience Raises $35 Million in Mezzanine Financing

CITY OF INDUSTRY, California – Prolacta Bioscience®, the nation’s leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million…  

Dec 06 2016

Metabolon Raises Additional $15 Million in Funding from Essex Woodlands

RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding…  

Dec 05 2016

Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities

RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, announced today that it has closed a financing that raised $15 million from…  

Aug 11 2016



View Legacy Fund news >